The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125391702 12539170 2 F 20160606 20160714 20160708 20160722 EXP JP-009507513-1606JPN010157 MERCK 99.00 YR F Y 0.00000 20160722 PH JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125391702 12539170 1 PS BELSOMRA SUVOREXANT 1 Oral 15 MG, QD 60 MG Y 204569 15 MG TABLET QD
125391702 12539170 2 SS BELSOMRA SUVOREXANT 1 60 MG Y 204569 TABLET
125391702 12539170 3 SS ROCEPHIN CEFTRIAXONE SODIUM 1 Intravenous drip 1 G, BID 16 G 0 1 G INJECTION BID
125391702 12539170 4 SS BFLUID AMINO ACIDSDEXTROSEELECTROLYTES NOSVITAMINS 1 Intravenous drip 500 ML, QD 8000 ML Y 0 500 ML INJECTION QD
125391702 12539170 5 SS BFLUID AMINO ACIDSDEXTROSEELECTROLYTES NOSVITAMINS 1 Intravenous drip 500 ML, QD 8000 ML Y 0 500 ML INJECTION QD
125391702 12539170 6 SS AMLODIN OD AMLODIPINE BESYLATE 1 Oral 5 MG, QD Y 0 5 MG TABLET QD
125391702 12539170 7 SS AMLODIN OD AMLODIPINE BESYLATE 1 Oral 5 MG, QD Y 0 5 MG TABLET QD
125391702 12539170 8 SS ZAFATEK TRELAGLIPTIN SUCCINATE 1 Oral 50 MG, QW 50 MG Y 0 50 MG TABLET /wk
125391702 12539170 9 SS ZAFATEK TRELAGLIPTIN SUCCINATE 1 Oral 50 MG, QW 50 MG Y 0 50 MG TABLET /wk
125391702 12539170 10 SS ASPARA K POTASSIUM ASPARTATE 1 Oral 2 G, TID Y 0 2 G POWDER TID
125391702 12539170 11 SS ASPARA K POTASSIUM ASPARTATE 1 Oral 2 G, TID Y 0 2 G POWDER TID
125391702 12539170 12 C LENDORMIN BROTIZOLAM 1 Oral 0.25 MG, DIVIDED DOSE FREQUENCY UNKNOWN 0 .25 MG POWDER QD
125391702 12539170 13 C BENZALIN NITRAZEPAM 1 Oral 2.5 MG, DIVIDED DOSE FREQUENCY UNKNOWN 25 MG 0 2.5 MG POWDER QD
125391702 12539170 14 C NYROZIN 2 Parenteral DAILY DOSE UNKNOWN 0 INJECTION
125391702 12539170 15 C ASCORBIC ACID. ASCORBIC ACID 1 Parenteral DAILY DOSE UNKNOWN 0 INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125391702 12539170 1 Insomnia
125391702 12539170 2 Restlessness
125391702 12539170 3 Infection
125391702 12539170 4 Decreased appetite
125391702 12539170 6 Hypertension
125391702 12539170 8 Diabetes mellitus
125391702 12539170 10 Hypokalaemia

Outcome of event

Event ID CASEID OUTC COD
125391702 12539170 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125391702 12539170 Hepatic function abnormal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125391702 12539170 1 20160602 20160605 0
125391702 12539170 3 20160521 20160528 0
125391702 12539170 4 20160521 20160605 0
125391702 12539170 5 20160615 20160630 0
125391702 12539170 6 20160605 0
125391702 12539170 7 20160615 0
125391702 12539170 8 20160605 0
125391702 12539170 9 20160615 0
125391702 12539170 10 20160605 0
125391702 12539170 11 20160615 0
125391702 12539170 12 20160525 0
125391702 12539170 13 20160524 20160602 0